JW Pharmaceutical Corporation (001067.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩49,700 (-0.10%) as of
Key statistics
- Market cap
- 1.13T
- Dividend yield
- 1.31%
- 52-week range
- 0.00 – 61,500.00
- Beta
- 1.02
- Revenue (TTM)
- 820.86B
- Profit margin
- 12.34%
About JW Pharmaceutical Corporation
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases, and pancreatic cancer. The company also provides infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Gwacheon-si, South Korea
- Employees
- 1,049
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.